Biopharmaceuticals

Privately owned company focusing on fermentation technologies, with production and recovery for cholesterol-lowering and alpha-glucosidase inhibitor drugs. Based in Calgary Alberta, Canada.

Offers novel platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation. Includes preclinical status of products, and details of corporation in Leiden, The Netherlands.

Company developing small-molecule drugs and recombinant DNA proteins, which regulate gene activity and genetic processes in cancer and other diseases. Includes product information for patients and professionals from San Diego, California. (Nasdaq: LGND)

Subsidiary of Unilever offering pilot plant for custom manufacturing or upscaling as well as the plug-in of genes into yeasts and filamentous fungi, followed by process development, and scale-up in Naarden, The Netherlands.

Developing drugs and therapies to reverse the effects of human aging by focusing on preserving the length of telomeres, to keep them more resilient. Careers in Reno, Nevada.

Development of superactive hormones and growth factors for therapeutic applications. Based in Rockville, Maryland, USA.

Discovers and develops therapeutics for treatment of diseases and disorders of the central nervous and immune systems, including anxiety, depression, alzheimer's disease, obesity, stroke and multiple sclerosis. (Nasdaq: NBIX).

Biopharmaceutical company specializing in oncology. (NASDAQ: CYTR)